Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) [Phase 1]
This is a Phase 1 trial evaluating Anvumetostat in combination with other therapies for advanced gastrointestinal, biliary tract, or pancrea…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer [Phase 2]
A Phase 2 study evaluating SHR-A1904 for biliary tract cancer is currently recruiting after prior systemic treatment failure.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of a combination therapy—gemcitabine/cisplatin (GemCis) with trastuzumab and …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating MP0317 in combination with chemoimmunotherapy as first-line treatment for advanced biliary tract carcino…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers [Phase 2]
A multicenter Phase 2 clinical trial evaluating Envafolimab for biliary tract cancers is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer [Phase 3]
Phase 3 trial evaluating zanidatamab plus standard-of-care versus standard-of-care alone in advanced HER2-positive biliary tract cancer; the…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating CDX-1140, a CD40 agonist, in combination with capecitabine, oxaliplatin (CAPOX), and pembrolizum…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]
AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating Adebrelimab in combination with gemcitabine, cisplatin, and simvastatin for advanced biliary tract …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) [Phase 2]
AstraZeneca's Dato-DXd is being studied as a single agent and in combination with other anti-cancer drugs in an ongoing Phase 2 trial for ad…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
This is a ClinicalTrials.gov study evaluating ctDNA-based genetic profiling in advanced biliary tract cancer. The trial is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
This CHA University-led clinical trial is evaluating ctDNA-based genetic profiling and its association with clinical outcomes in advanced bi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Clinical trial update describing investigation of predictive biomarkers in patients with advanced biliary tract cancer treated with lenvatin…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies [Phase 2]
A Phase 2 clinical trial evaluating the combination of vebotolimab and Ptorlimab for EGFR-positive advanced biliary tract cancers is not yet…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) [Phase 3]
This document reports an ongoing Phase 3 trial evaluating rilvegostomig or durvalumab plus chemotherapy as first-line treatment for biliary …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
This clinical trial update reports activity of regorafenib in combination with chemotherapy in patients with advanced biliary tract cancer a…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] [Phase 2]
Phase 2 clinical study of LBL-024 in combination therapy for advanced solid tumors is currently recruiting, with substudy focusing on biliar…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
The TRACE-BTC study is a real-world cohort investigation examining how biomarkers and patient-reported quality of life relate to outcomes in…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TJ033721 (Givastomig) in adults with advanced or metastatic solid tumors; the study is currently recruiting and inc…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of AK130 in combination with AK112 for advanced biliary tract cancer, currently rec…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers [Phase 2, Phase 3]
A clinical trial update indicates Mitazalimab is being tested in combination with standard chemotherapy for immunotherapy-resistant advanced…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Ligufalimab and Cadonilimab in Advanced Liver Cancers [Phase 2]
Phase 2 clinical trial update on Ligufalimab and Cadonilimab in advanced hepatocellular carcinoma and biliary tract cancer, currently recrui…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Combination Immunotherapy in Rare Cancers Under InvesTigation [Phase 2]
This is a Phase 2 trial update describing a combination immunotherapy study for rare cancers; the trial is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
This document describes a post-marketing observational study of Tasfygo for unresectable biliary tract cancer with FGFR2 fusion after chemot…